However, our understanding of AR function in NASH is far from being complete and, importantly, whether and how AR regulates human (h) HSCs, the major cellular determinant of hepatic fibrosis in NASH, and plays a role in demographically important specific human liver diseases such as NAFLD/NASH is under study. This evidence concerns the gene AR and metabolic dysfunction-associated steatotic liver disease.